Self-carried nanodrug (SCND-SIS3): A targeted therapy for lung cancer with superior biocompatibility and immune boosting effects
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Self-carried nanodrug (SCND-SIS3): A targeted therapy for lung cancer with superior biocompatibility and immune boosting effects
Authors
Keywords
-
Journal
BIOMATERIALS
Volume -, Issue -, Pages 121730
Publisher
Elsevier BV
Online
2022-08-12
DOI
10.1016/j.biomaterials.2022.121730
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Evolution of systemic therapy for stages I–III non-metastatic non-small-cell lung cancer
- (2021) Jamie E. Chaft et al. Nature Reviews Clinical Oncology
- JASPAR 2022: the 9th release of the open-access database of transcription factor binding profiles
- (2021) Jaime A Castro-Mondragon et al. NUCLEIC ACIDS RESEARCH
- NK cells for cancer immunotherapy
- (2020) Noriko Shimasaki et al. NATURE REVIEWS DRUG DISCOVERY
- The NK cell–cancer cycle: advances and new challenges in NK cell–based immunotherapies
- (2020) Tobias Bald et al. NATURE IMMUNOLOGY
- On-Target Anti-TGF-β Therapies Are Not Succeeding in Clinical Cancer Treatments: What Are Remaining Challenges?
- (2020) Adilson Fonseca Teixeira et al. Frontiers in Cell and Developmental Biology
- Exploring the NK cell platform for cancer immunotherapy
- (2020) Jacob A. Myers et al. Nature Reviews Clinical Oncology
- Arenavirus Induced CCL5 Expression Causes NK Cell-Mediated Melanoma Regression
- (2020) Hilal Bhat et al. Frontiers in Immunology
- Advances and perspectives in carrier-free nanodrugs for cancer chemo-monotherapy and combination therapy
- (2020) Li Huang et al. BIOMATERIALS
- Transforming Growth Factor-β Signaling in Immunity and Cancer
- (2019) Eduard Batlle et al. IMMUNITY
- CCL5 promotes breast cancer recurrence through macrophage recruitment in residual tumors
- (2019) Andrea Walens et al. eLife
- Prognostic value of TGF-β in lung cancer: systematic review and meta-analysis
- (2019) Jue Li et al. BMC CANCER
- CCR4 Blockade Depletes Regulatory T Cells and Prolongs Survival in a Canine Model of Bladder Cancer
- (2019) Shingo Maeda et al. Cancer Immunology Research
- Natural killer cell recruitment and activation are regulated by CD47 expression in the tumor microenvironment
- (2019) Pulak Ranjan Nath et al. Cancer Immunology Research
- Systemic Therapy for Locally Advanced and Metastatic Non–Small Cell Lung Cancer
- (2019) Kathryn C. Arbour et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control
- (2018) Jan P. Böttcher et al. CELL
- The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2018 update
- (2018) Enis Afgan et al. NUCLEIC ACIDS RESEARCH
- Metformin suppresses melanoma progression by inhibiting KAT5-mediated SMAD3 acetylation, transcriptional activity and TRIB3 expression
- (2018) Ke Li et al. ONCOGENE
- Enhanced cancer immunotherapy with Smad3-slilencing NK-92 cells
- (2018) Qing Ming Wang et al. Cancer Immunology Research
- CCL1 is a major regulatory T cell attracting factor in human breast cancer
- (2018) Benjamin Kuehnemuth et al. BMC CANCER
- Clearance in Drug Design
- (2018) Dennis A. Smith et al. JOURNAL OF MEDICINAL CHEMISTRY
- TGF-β-associated extracellular matrix genes link cancer-associated fibroblasts to immune evasion and immunotherapy failure
- (2018) Ankur Chakravarthy et al. Nature Communications
- Smad3 promotes cancer progression by inhibiting E4BP4-mediated NK cell development
- (2017) Patrick Ming-Kuen Tang et al. Nature Communications
- Analysis of nanoparticle delivery to tumours
- (2016) Stefan Wilhelm et al. Nature Reviews Materials
- The TGF-β Signaling Regulator PMEPA1 Suppresses Prostate Cancer Metastases to Bone
- (2015) Pierrick G.J. Fournier et al. CANCER CELL
- Principles of nanoparticle design for overcoming biological barriers to drug delivery
- (2015) Elvin Blanco et al. NATURE BIOTECHNOLOGY
- Memory-T-Cell-Derived Interferon-γ Instructs Potent Innate Cell Activation for Protective Immunity
- (2014) Saïdi M’Homa Soudja et al. IMMUNITY
- TGF- Utilizes SMAD3 to Inhibit CD16-Mediated IFN- Production and Antibody-Dependent Cellular Cytotoxicity in Human NK Cells
- (2014) R. Trotta et al. JOURNAL OF IMMUNOLOGY
- Preparation and Size Control of Sub-100 nm Pure Nanodrugs
- (2014) Jinfeng Zhang et al. NANO LETTERS
- Murine natural killer immunoreceptors use distinct proximal signaling complexes to direct cell function
- (2013) R. M. May et al. BLOOD
- Renal clearable inorganic nanoparticles: a new frontier of bionanotechnology
- (2013) Jinbin Liu et al. Materials Today
- Polymer nanogels: A versatile nanoscopic drug delivery platform
- (2012) Reuben T. Chacko et al. ADVANCED DRUG DELIVERY REVIEWS
- The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo
- (2012) Hiroshi Maeda et al. ADVANCED DRUG DELIVERY REVIEWS
- Tumor-Derived Chemokine CCL5 Enhances TGF- -Mediated Killing of CD8+ T Cells in Colon Cancer by T-Regulatory Cells
- (2012) L.-Y. Chang et al. CANCER RESEARCH
- Molecular Pathways: Targeting the TGF- Pathway for Cancer Therapy
- (2012) A. L. Smith et al. CLINICAL CANCER RESEARCH
- Complexities of TGF-β Targeted Cancer Therapy
- (2012) Erin C. Connolly et al. International Journal of Biological Sciences
- HER2/HER3 Signaling Regulates NK Cell-Mediated Cytotoxicity via MHC Class I Chain-Related Molecule A and B Expression in Human Breast Cancer Cell Lines
- (2012) R. Okita et al. JOURNAL OF IMMUNOLOGY
- TGF-β is responsible for NK cell immaturity during ontogeny and increased susceptibility to infection during mouse infancy
- (2012) Jeffrey P Marcoe et al. NATURE IMMUNOLOGY
- Outgrowth of Drug-Resistant Carcinomas Expressing Markers of Tumor Aggression after Long-term T RI/II Kinase Inhibition with LY2109761
- (2011) E. C. Connolly et al. CANCER RESEARCH
- Cancer invasion and resistance: interconnected processes of disease progression and therapy failure
- (2011) Stephanie Alexander et al. TRENDS IN MOLECULAR MEDICINE
- Leptin Signaling Protects NK Cells from Apoptosis During Development in Mouse Bone Marrow
- (2010) Cherry Kam Chun Lo et al. Cellular & Molecular Immunology
- Properties and emerging applications of self-assembled structures made from inorganic nanoparticles
- (2009) Zhihong Nie et al. Nature Nanotechnology
- Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis
- (2009) M Petersen et al. ONCOGENE
- Pharmacokinetics and Biodistribution of Nanoparticles
- (2008) Shyh-Dar Li et al. MOLECULAR PHARMACEUTICS
- Up on the tightrope: natural killer cell activation and inhibition
- (2008) Lewis L Lanier NATURE IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now